Strides Pharma Sciences rallied 8.44% to Rs 1,037.60 after the company received establishment inspection (EIR) from the US Food and Drug Administration (USFDA), indicating the successful closure of the inspection conducted at the Bengaluru facility.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.